5-Amino-1MQ Reconstitution and Dosage: A Practical Research Guide

5-amino-1MQ reconstitution and dosage comes down to two numbers: how much bacteriostatic water you add to the vial, and how much solution you draw into a syringe. A 10 mg vial mixed with 2 mL of bacteriostatic water makes a 5 mg/mL solution, so 0.1 mL — 10 units on a U-100 insulin syringe — equals 500 mcg. 5-amino-1MQ is not FDA-approved for human use, and no official human dosage exists; every figure below reflects published preclinical work or community-reported research protocols, not medical guidance.

What 5-Amino-1MQ Actually Is

5-amino-1MQ (also written 5-amino-1-methylquinolinium) is a small synthetic molecule studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. It is not a peptide, even though it is frequently sold alongside peptides and discussed in the same research forums.

Preclinical work has examined NNMT inhibition in relation to fat cell metabolism and energy expenditure in cell and animal models. Those findings have not been translated into approved human treatments.

The compound is sold as oral capsules and as a lyophilized powder in sealed vials. Only the powder form requires reconstitution, which is why the 5 amino 1MQ spelling usually appears in the context of mixing and syringe math.

How to Reconstitute 5-Amino-1MQ Powder

Reconstitution means dissolving the lyophilized powder in bacteriostatic water so it can be measured accurately with a syringe. Sterile technique matters more than speed here.

1. Clean the vial stopper and your work surface with an alcohol swab and let both dry completely.
2. Draw the chosen volume of bacteriostatic water into a new syringe.
3. Insert the needle through the stopper and aim the stream at the glass wall, not directly at the powder.
4. Swirl the vial gently until the powder dissolves. Do not shake it, since shaking can create foam that makes measuring harder.
5. Label the vial with the concentration and the date, then refrigerate it protected from light.

Most people add 1 to 5 mL of bacteriostatic water, depending on vial size. A larger water volume produces a weaker concentration, which makes small doses easier to measure precisely but increases the injection volume. For a broader walkthrough of mixing technique and syringe math, see this peptide reconstitution and dosage guide.

5-Amino-1MQ Reconstitution Chart

Use the table below to find the concentration your vial will produce and the volume needed for common research amounts.

Vial size	BAC water added	Concentration	500 mcg (0.5 mg)	1 mg	2 mg
5 mg	1 mL	5 mg/mL	0.1 mL (10 units)	0.2 mL (20 units)	0.4 mL (40 units)
5 mg	2 mL	2.5 mg/mL	0.2 mL (20 units)	0.4 mL (40 units)	0.8 mL (80 units)
10 mg	2 mL	5 mg/mL	0.1 mL (10 units)	0.2 mL (20 units)	0.4 mL (40 units)
10 mg	5 mL	2 mg/mL	0.25 mL (25 units)	0.5 mL (50 units)	1.0 mL (100 units)
50 mg	10 mL	5 mg/mL	0.1 mL (10 units)	0.2 mL (20 units)	0.4 mL (40 units)

On a U-100 insulin syringe, 1 unit equals 0.01 mL, which is why 0.1 mL and 10 units describe the same volume.

Reported Dosage Ranges in Research Settings

There is no established human dose of 5-amino-1MQ. Animal studies used body-weight-adjusted doses that cannot be converted directly into a human protocol.

Community-reported figures cluster around two very different ranges:

• Subcutaneous: roughly 0.5 to 2 mg per day, often given as one or two injections.
• Oral: roughly 100 to 150 mg per day, because oral bioavailability of the compound appears to be low.

Reported 5-amino-1mq subcutaneous injection dosage is far smaller than the oral range because injection bypasses first-pass metabolism in the liver. These numbers are anecdotes collected from forums, not clinical guidance, and individual response varies.

5-Amino-1MQ Oral vs Injection

The two routes are not interchangeable on a milligram-for-milligram basis, and the difference is large.

Route	Typical reported amount	Equipment needed	Notes
Oral capsule	100 to 150 mg per day	None	Convenient, but requires far more material and is often linked to stomach discomfort
Subcutaneous injection	0.5 to 2 mg per day	BAC water, syringes, refrigeration	Smaller amounts, sterile technique required, injection-site irritation possible

Choosing between 5-amino-1mq oral vs injection usually comes down to tolerance for needles versus cost per milligram, since oral use consumes far more compound.

Doing the Math With a Calculator

Any 5-amino-1mq dosage calculator relies on the same three-step formula, and you can run it yourself:

1. Concentration = total milligrams in the vial ÷ milliliters of water added.
2. Volume to draw = desired dose in milligrams ÷ concentration.
3. Units on a U-100 syringe = volume in mL × 100.

Example: a 10 mg vial with 2 mL of water gives 5 mg/mL. For a 1 mg research dose, draw 1 ÷ 5 = 0.2 mL, which is 20 units.

Double-check every calculation before drawing a syringe. A misplaced decimal can change a dose tenfold.

Storage and Stability After Mixing

A reconstituted vial should stay refrigerated at roughly 2 to 8 °C and be kept out of direct light. Bacteriostatic water contains benzyl alcohol, which slows bacterial growth and extends usable life compared with plain sterile water.

Freezing reconstituted solution is not recommended, since repeated freeze-thaw cycles can degrade the compound. Discard any vial that shows cloudiness, particles, or a color change.

How It Compares With Other Metabolic Research Compounds

5-amino-1MQ is often grouped with metabolic and mitochondrial research agents such as SLU-PP-332 and MOTS-c, but the mechanisms are not the same. 5-amino-1MQ targets NNMT activity, SLU-PP-332 is studied as an estrogen-related receptor agonist, and MOTS-c is a mitochondrial-derived peptide.

Because the pathways differ, results from one compound do not predict results from another, and stacking them has no established safety data.

Safety, Sourcing, and Legal Status

5-amino-1MQ is not approved by the FDA for human use in the United States. Vials sold online are labeled for laboratory research only, and purity varies widely between suppliers.

Known unknowns include human pharmacokinetics, long-term safety, and interactions with prescription medications that affect metabolism. Anyone considering use should discuss it with a licensed healthcare professional first. This article is informational and is not medical advice.

If you are researching 5-amino-1mq where to buy, look for vendors that publish third-party certificates of analysis with HPLC purity data, ship with cold packs, and label the compound and its lot number clearly. Listings without documentation are the most common source of underdosed or mislabeled product.

COMMON QUESTIONS

Frequently Asked Questions

How much bacteriostatic water should I add to a 5-amino-1MQ vial?

The right volume depends on the vial size and the concentration you want. A 5 mg vial with 1 mL of bacteriostatic water gives 5 mg/mL, while the same vial with 2 mL gives 2.5 mg/mL. Adding more water makes small doses easier to measure accurately, but it also increases the volume you inject.

What is a typical 5-amino-1MQ dosage?

No FDA-approved human dosage exists for 5-amino-1MQ. Community-reported research figures range from about 0.5 to 2 mg per day subcutaneously and roughly 100 to 150 mg per day orally. These are anecdotes rather than clinical data, and no human safety profile has been established.

Is 5-amino-1MQ a peptide?

No. 5-amino-1MQ is a small synthetic molecule studied as an NNMT inhibitor, not a peptide, even though it is often sold and discussed alongside peptides. It is marketed as a research chemical for laboratory use and is not approved for human consumption.